High-performance solutions
globally
We believe that personal contact is essential for a competent consultation and tailor-made products and solutions. Wherever possible – in our home market of Germany – we therefore rely on direct sales.
We founded subsidiaries in the large and important markets of the USA and France in 2006 and 2017.
In over 50 export countries around the globe, exclusive specialist dealers ensure that users receive comprehensive and reliable support.
Headquarters
Ulm, Germany
Since we were founded in 1912, our company has been headquartered in Ulm. Having initially been located on Münsterplatz, we have been at our current headquarters in Ulm-Jungingen since 1992. This is where we develop and manufacture our medical devices with more than 110 years of expertise. And there, we continuously invest in our infrastructure and in the people who make the company what it is.
Subsidiary ulrich medical USA
Dallas, Texas, USA
In order to expand our business success internationally, we founded the subsidiary ulrich medical USA, Inc. in January 2006. It has been headquartered in Dallas, Texas, since 2023.
In addition to the direct sales of our existing spinal systems, we also develop new products specifically tailored to the needs of the US market. The implants are manufactured in Germany.
The move to the USA has paid off: the subsidiary has consistently recorded double-digit growth figures in recent years.
Click here to go directly to the website of our US colleagues.
Sales subsidiary ulrich medical France
Toulouse, France
In October 2017, we decided to focus on cultivating Europe’s second-largest medical technology market. To this end, we have founded a wholly owned subsidiary in France: ulrich medical France SAS, headquartered in Toulouse. Sales in France initially focused on our contrast media injectors; in 2021, we expanded it to include our spinal systems.
Sales subsidiary ulrich medical España
Madrid, Spain
Since October 2024, we have also been selling our contrast media injectors directly in Spain via our own subsidiary. This strengthens our international presence, increases our brand awareness and also expands our market share in this important European medical technology market.